Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

41 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A population pharmacokinetic analysis of zanamivir in subjects with experimental and naturally occurring influenza: effects of formulation and route of administration.
Peng AW, Hussey EK, Moore KH. Peng AW, et al. J Clin Pharmacol. 2000 Mar;40(3):242-9. doi: 10.1177/00912700022008900. J Clin Pharmacol. 2000. PMID: 10709152 Clinical Trial.
A Novel Method for Studying the Pharmacokinetics of [(14) C]Umeclidinium After Application to the Axilla or Palm of Healthy Male Subjects.
Pene Dumitrescu T, Santos LL, Hughes SC, Pereira AI, Young GC, Hussey E, Charlton P, Baptiste-Brown S, Stuart JS, Vincent V, van Marle SP, Schmith VD. Pene Dumitrescu T, et al. Clin Transl Sci. 2016 Aug;9(4):183-91. doi: 10.1111/cts.12406. Epub 2016 Jun 15. Clin Transl Sci. 2016. PMID: 27304394 Free PMC article. Clinical Trial.
Safety, pharmacokinetics and pharmacodynamics of remogliflozin etabonate, a novel SGLT2 inhibitor, and metformin when co-administered in subjects with type 2 diabetes mellitus.
Hussey EK, Kapur A, O'Connor-Semmes R, Tao W, Rafferty B, Polli JW, James CD Jr, Dobbins RL. Hussey EK, et al. BMC Pharmacol Toxicol. 2013 Apr 30;14:25. doi: 10.1186/2050-6511-14-25. BMC Pharmacol Toxicol. 2013. PMID: 23631443 Free PMC article. Clinical Trial.
Single-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy volunteers and patients with type 2 diabetes mellitus.
Hussey EK, Clark RV, Amin DM, Kipnes MS, O'Connor-Semmes RL, O'Driscoll EC, Leong J, Murray SC, Dobbins RL, Layko D, Nunez DJ. Hussey EK, et al. J Clin Pharmacol. 2010 Jun;50(6):623-35. doi: 10.1177/0091270009351879. Epub 2010 Jan 7. J Clin Pharmacol. 2010. PMID: 20056803 Clinical Trial.
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study.
Hussey EK, Dobbins RL, Stoltz RR, Stockman NL, O'Connor-Semmes RL, Kapur A, Murray SC, Layko D, Nunez DJ. Hussey EK, et al. J Clin Pharmacol. 2010 Jun;50(6):636-46. doi: 10.1177/0091270009352185. Epub 2010 Mar 3. J Clin Pharmacol. 2010. PMID: 20200268 Clinical Trial.
Relative Bioavailability of an Emulsion Formulation for Omega-3-Acid Ethyl Esters Compared to the Commercially Available Formulation: A Randomized, Parallel-Group, Single-Dose Study Followed by Repeat Dosing in Healthy Volunteers.
Hussey EK, Portelli S, Fossler MJ, Gao F, Harris WS, Blum RA, Lates CD, Gould E, Abu-Baker O, Johnson S, Reddy KK. Hussey EK, et al. Clin Pharmacol Drug Dev. 2012 Jan;1(1):14-23. doi: 10.1177/2160763X11431107. Clin Pharmacol Drug Dev. 2012. PMID: 27206142
Population pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.
Moore KH, Yuen GJ, Hussey EK, Pakes GE, Eron JJ Jr, Bartlett JA. Moore KH, et al. Antimicrob Agents Chemother. 1999 Dec;43(12):3025-9. doi: 10.1128/AAC.43.12.3025. Antimicrob Agents Chemother. 1999. PMID: 10582904 Free PMC article. Clinical Trial.
Interspecies scaling and pharmacokinetic parameters of 3TC in humans.
Hussey EK, Donn KH, Daniel MJ, Hall ST, Harker AJ, Evans GL. Hussey EK, et al. J Clin Pharmacol. 1994 Oct;34(10):975-7. doi: 10.1002/j.1552-4604.1994.tb01968.x. J Clin Pharmacol. 1994. PMID: 7530728 Clinical Trial.
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients.
Dobbins RL, O'Connor-Semmes R, Kapur A, Kapitza C, Golor G, Mikoshiba I, Tao W, Hussey EK. Dobbins RL, et al. Diabetes Obes Metab. 2012 Jan;14(1):15-22. doi: 10.1111/j.1463-1326.2011.01462.x. Epub 2011 Oct 30. Diabetes Obes Metab. 2012. PMID: 21733056 Clinical Trial.
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole.
Moore KH, Yuen GJ, Raasch RH, Eron JJ, Martin D, Mydlow PK, Hussey EK. Moore KH, et al. Clin Pharmacol Ther. 1996 May;59(5):550-8. doi: 10.1016/S0009-9236(96)90183-6. Clin Pharmacol Ther. 1996. PMID: 8646826 Clinical Trial.
41 results
Jump to page
Feedback